Outlook Therapeutics, Inc.

Q2 2024 13F Holders

Symbol
OTLK
CUSIP
69012T305
Type
Equity
Class
COM
Num filings
68
Total reported value, excl. options
$59.5 M
Manager Report Date Value ($000) Shares Option Type